Keyphrases
Monotherapy
100%
Vancomycin
100%
Methicillin-resistant Staphylococcus Aureus
100%
Critical Illness
100%
Influenza
100%
Co-infection
100%
Bacterial Infection
33%
Confidence Interval
22%
Relative Risk
22%
Antibiotics
22%
Critically Ill children
22%
Methicillin-resistant Staphylococcus Aureus Pneumonia
22%
Anti-methicillin-resistant Staphylococcus Aureus
22%
Hospitalization
11%
Clinical Treatment
11%
Respiratory Failure
11%
Clinical Outcomes
11%
Life-threatening
11%
Acute Lung Injury
11%
Clinical Characteristics
11%
Antibiotic Use
11%
Clinical Course
11%
Influenza-like Illness
11%
Influenza Virus
11%
Baseline Characteristics
11%
Pediatric Intensive Care Unit
11%
Antimicrobial Activity
11%
Fatality
11%
Leukopenia
11%
Virus Resistance
11%
Necrotizing Pneumonia
11%
Severe Cases
11%
Influenza B
11%
Extracorporeal Life Support
11%
Vancomycin Dosing
11%
Influenza A
11%
Pneumonia in children
11%
Trough Level
11%
Vasopressor Use
11%
Medicine and Dentistry
Monotherapy
100%
Vancomycin
100%
Mixed Infection
100%
Critical Illness
100%
Methicillin Resistant Staphylococcus Aureus
100%
Methicillin Resistant Staphylococcus Aureus Infection
18%
Hypertensive Factor
9%
Intensive Care
9%
Antiinfective Agent
9%
Intensive Care Unit
9%
Disease Course
9%
Respiratory Failure
9%
Acute Lung Injury
9%
Leukopenia
9%
Influenza Virus
9%
Necrotizing Pneumonia
9%
Fatality
9%
Extracorporeal Life Support
9%
Influenza A
9%
Trough Level
9%
Influenza B
9%
Pharmacology, Toxicology and Pharmaceutical Science
Monotherapy
100%
Mixed Infection
100%
Methicillin-Resistant Staphylococcus Aureus
100%
Critical Illness
100%
Vancomycin
100%
Methicillin Resistant Staphylococcus Aureus Infection
18%
Respiratory Failure
9%
Acute Lung Injury
9%
Hypertensive Factor
9%
Disease Course
9%
Antiinfective Agent
9%
Necrotizing Pneumonia
9%
Influenza Virus
9%
Trough Level
9%
Influenza A
9%
Leukopenia
9%
Fatality
9%
Influenza B
9%
Immunology and Microbiology
Methicillin-Resistant Staphylococcus Aureus
100%
Influenza
100%
Coinfection
100%
Influenza Virus
7%
Infection
7%